nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—CYP2C19—Lapatinib—breast cancer	0.0163	0.666	CbGbCtD
Methsuximide—CYP2C19—Tamoxifen—breast cancer	0.00814	0.334	CbGbCtD
Methsuximide—Aminophenazone—CYP17A1—breast cancer	0.00432	0.209	CrCbGaD
Methsuximide—Ethotoin—SCN10A—breast cancer	0.00206	0.0994	CrCbGaD
Methsuximide—Phenobarbital—ABCC1—breast cancer	0.0012	0.0582	CrCbGaD
Methsuximide—Aminophenazone—CYP2D6—breast cancer	0.0012	0.0582	CrCbGaD
Methsuximide—Antipyrine—PTGS1—breast cancer	0.00111	0.0538	CrCbGaD
Methsuximide—Aminophenazone—CYP3A4—breast cancer	0.00103	0.0499	CrCbGaD
Methsuximide—Phenobarbital—CYP1B1—breast cancer	0.000921	0.0445	CrCbGaD
Methsuximide—Glutethimide—CYP2D6—breast cancer	0.000904	0.0437	CrCbGaD
Methsuximide—Tension—Paclitaxel—breast cancer	0.00084	0.00141	CcSEcCtD
Methsuximide—Nervousness—Paclitaxel—breast cancer	0.000832	0.00139	CcSEcCtD
Methsuximide—Diarrhoea—Tamoxifen—breast cancer	0.000831	0.00139	CcSEcCtD
Methsuximide—Irritability—Methotrexate—breast cancer	0.000829	0.00139	CcSEcCtD
Methsuximide—Confusional state—Fluorouracil—breast cancer	0.000828	0.00139	CcSEcCtD
Methsuximide—Dizziness—Vinblastine—breast cancer	0.000827	0.00138	CcSEcCtD
Methsuximide—Urticaria—Vinorelbine—breast cancer	0.000825	0.00138	CcSEcCtD
Methsuximide—Abdominal pain—Vinorelbine—breast cancer	0.000821	0.00137	CcSEcCtD
Methsuximide—Feeling abnormal—Thiotepa—breast cancer	0.000818	0.00137	CcSEcCtD
Methsuximide—Anorexia—Irinotecan—breast cancer	0.000817	0.00137	CcSEcCtD
Methsuximide—Anorexia—Mitoxantrone—breast cancer	0.000817	0.00137	CcSEcCtD
Methsuximide—Ataxia—Methotrexate—breast cancer	0.000817	0.00137	CcSEcCtD
Methsuximide—Diarrhoea—Melphalan—breast cancer	0.000814	0.00136	CcSEcCtD
Methsuximide—Gastrointestinal pain—Thiotepa—breast cancer	0.000811	0.00136	CcSEcCtD
Methsuximide—Nausea—Chlorambucil—breast cancer	0.00081	0.00136	CcSEcCtD
Methsuximide—Vision blurred—Paclitaxel—breast cancer	0.000807	0.00135	CcSEcCtD
Methsuximide—Dizziness—Tamoxifen—breast cancer	0.000803	0.00134	CcSEcCtD
Methsuximide—Anorexia—Gemcitabine—breast cancer	0.000796	0.00133	CcSEcCtD
Methsuximide—Vomiting—Vinblastine—breast cancer	0.000795	0.00133	CcSEcCtD
Methsuximide—Diarrhoea—Goserelin—breast cancer	0.000794	0.00133	CcSEcCtD
Methsuximide—Erythema multiforme—Docetaxel—breast cancer	0.000788	0.00132	CcSEcCtD
Methsuximide—Urticaria—Thiotepa—breast cancer	0.000788	0.00132	CcSEcCtD
Methsuximide—Abdominal pain—Thiotepa—breast cancer	0.000784	0.00131	CcSEcCtD
Methsuximide—Headache—Vinblastine—breast cancer	0.000783	0.00131	CcSEcCtD
Methsuximide—Anorexia—Fluorouracil—breast cancer	0.000782	0.00131	CcSEcCtD
Methsuximide—Insomnia—Irinotecan—breast cancer	0.000775	0.0013	CcSEcCtD
Methsuximide—Vomiting—Tamoxifen—breast cancer	0.000772	0.00129	CcSEcCtD
Methsuximide—Dizziness—Goserelin—breast cancer	0.000767	0.00128	CcSEcCtD
Methsuximide—Leukopenia—Paclitaxel—breast cancer	0.000766	0.00128	CcSEcCtD
Methsuximide—Rash—Tamoxifen—breast cancer	0.000766	0.00128	CcSEcCtD
Methsuximide—Dermatitis—Tamoxifen—breast cancer	0.000765	0.00128	CcSEcCtD
Methsuximide—Ataxia—Epirubicin—breast cancer	0.000764	0.00128	CcSEcCtD
Methsuximide—Erythema multiforme—Capecitabine—breast cancer	0.000763	0.00128	CcSEcCtD
Methsuximide—Somnolence—Irinotecan—breast cancer	0.000762	0.00127	CcSEcCtD
Methsuximide—Somnolence—Mitoxantrone—breast cancer	0.000762	0.00127	CcSEcCtD
Methsuximide—Headache—Tamoxifen—breast cancer	0.000761	0.00127	CcSEcCtD
Methsuximide—Antipyrine—CYP2D6—breast cancer	0.000758	0.0366	CrCbGaD
Methsuximide—Vomiting—Melphalan—breast cancer	0.000756	0.00127	CcSEcCtD
Methsuximide—Insomnia—Gemcitabine—breast cancer	0.000755	0.00126	CcSEcCtD
Methsuximide—Rash—Melphalan—breast cancer	0.00075	0.00126	CcSEcCtD
Methsuximide—Dermatitis—Melphalan—breast cancer	0.000749	0.00125	CcSEcCtD
Methsuximide—Decreased appetite—Mitoxantrone—breast cancer	0.000745	0.00125	CcSEcCtD
Methsuximide—Decreased appetite—Irinotecan—breast cancer	0.000745	0.00125	CcSEcCtD
Methsuximide—Eosinophilia—Methotrexate—breast cancer	0.000743	0.00124	CcSEcCtD
Methsuximide—Nausea—Vinblastine—breast cancer	0.000743	0.00124	CcSEcCtD
Methsuximide—Insomnia—Fluorouracil—breast cancer	0.000742	0.00124	CcSEcCtD
Methsuximide—Somnolence—Gemcitabine—breast cancer	0.000742	0.00124	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Irinotecan—breast cancer	0.00074	0.00124	CcSEcCtD
Methsuximide—Vomiting—Goserelin—breast cancer	0.000738	0.00123	CcSEcCtD
Methsuximide—Constipation—Mitoxantrone—breast cancer	0.000733	0.00123	CcSEcCtD
Methsuximide—Constipation—Irinotecan—breast cancer	0.000733	0.00123	CcSEcCtD
Methsuximide—Rash—Goserelin—breast cancer	0.000731	0.00122	CcSEcCtD
Methsuximide—Dermatitis—Goserelin—breast cancer	0.000731	0.00122	CcSEcCtD
Methsuximide—Somnolence—Fluorouracil—breast cancer	0.00073	0.00122	CcSEcCtD
Methsuximide—Headache—Goserelin—breast cancer	0.000727	0.00122	CcSEcCtD
Methsuximide—Decreased appetite—Gemcitabine—breast cancer	0.000726	0.00121	CcSEcCtD
Methsuximide—Nausea—Tamoxifen—breast cancer	0.000721	0.00121	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000721	0.00121	CcSEcCtD
Methsuximide—Constipation—Gemcitabine—breast cancer	0.000714	0.00119	CcSEcCtD
Methsuximide—Decreased appetite—Fluorouracil—breast cancer	0.000713	0.00119	CcSEcCtD
Methsuximide—Pancytopenia—Methotrexate—breast cancer	0.000713	0.00119	CcSEcCtD
Methsuximide—Diarrhoea—Vinorelbine—breast cancer	0.000711	0.00119	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000709	0.00119	CcSEcCtD
Methsuximide—Ataxia—Doxorubicin—breast cancer	0.000707	0.00118	CcSEcCtD
Methsuximide—Nausea—Melphalan—breast cancer	0.000706	0.00118	CcSEcCtD
Methsuximide—Feeling abnormal—Mitoxantrone—breast cancer	0.000706	0.00118	CcSEcCtD
Methsuximide—Feeling abnormal—Irinotecan—breast cancer	0.000706	0.00118	CcSEcCtD
Methsuximide—Confusional state—Paclitaxel—breast cancer	0.000705	0.00118	CcSEcCtD
Methsuximide—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000701	0.00117	CcSEcCtD
Methsuximide—Gastrointestinal pain—Irinotecan—breast cancer	0.000701	0.00117	CcSEcCtD
Methsuximide—Eosinophilia—Epirubicin—breast cancer	0.000696	0.00116	CcSEcCtD
Methsuximide—Nausea—Goserelin—breast cancer	0.000689	0.00115	CcSEcCtD
Methsuximide—Feeling abnormal—Gemcitabine—breast cancer	0.000688	0.00115	CcSEcCtD
Methsuximide—Dizziness—Vinorelbine—breast cancer	0.000687	0.00115	CcSEcCtD
Methsuximide—Urticaria—Mitoxantrone—breast cancer	0.000681	0.00114	CcSEcCtD
Methsuximide—Diarrhoea—Thiotepa—breast cancer	0.000679	0.00114	CcSEcCtD
Methsuximide—Abdominal pain—Mitoxantrone—breast cancer	0.000677	0.00113	CcSEcCtD
Methsuximide—Abdominal pain—Irinotecan—breast cancer	0.000677	0.00113	CcSEcCtD
Methsuximide—Feeling abnormal—Fluorouracil—breast cancer	0.000676	0.00113	CcSEcCtD
Methsuximide—Drowsiness—Methotrexate—breast cancer	0.000669	0.00112	CcSEcCtD
Methsuximide—Pancytopenia—Epirubicin—breast cancer	0.000667	0.00112	CcSEcCtD
Methsuximide—Anorexia—Paclitaxel—breast cancer	0.000666	0.00111	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000664	0.00111	CcSEcCtD
Methsuximide—Vision blurred—Capecitabine—breast cancer	0.000662	0.00111	CcSEcCtD
Methsuximide—Vomiting—Vinorelbine—breast cancer	0.000661	0.00111	CcSEcCtD
Methsuximide—Dizziness—Thiotepa—breast cancer	0.000656	0.0011	CcSEcCtD
Methsuximide—Rash—Vinorelbine—breast cancer	0.000655	0.0011	CcSEcCtD
Methsuximide—Dermatitis—Vinorelbine—breast cancer	0.000655	0.0011	CcSEcCtD
Methsuximide—Urticaria—Fluorouracil—breast cancer	0.000652	0.00109	CcSEcCtD
Methsuximide—Headache—Vinorelbine—breast cancer	0.000651	0.00109	CcSEcCtD
Methsuximide—Antipyrine—CYP3A4—breast cancer	0.00065	0.0314	CrCbGaD
Methsuximide—Leukopenia—Docetaxel—breast cancer	0.00065	0.00109	CcSEcCtD
Methsuximide—Eosinophilia—Doxorubicin—breast cancer	0.000644	0.00108	CcSEcCtD
Methsuximide—Haematuria—Methotrexate—breast cancer	0.000638	0.00107	CcSEcCtD
Methsuximide—Antipyrine—PTGS2—breast cancer	0.000636	0.0307	CrCbGaD
Methsuximide—Weight decreased—Epirubicin—breast cancer	0.000636	0.00106	CcSEcCtD
Methsuximide—Insomnia—Paclitaxel—breast cancer	0.000632	0.00106	CcSEcCtD
Methsuximide—Vomiting—Thiotepa—breast cancer	0.000631	0.00106	CcSEcCtD
Methsuximide—Leukopenia—Capecitabine—breast cancer	0.000629	0.00105	CcSEcCtD
Methsuximide—Drowsiness—Epirubicin—breast cancer	0.000626	0.00105	CcSEcCtD
Methsuximide—Rash—Thiotepa—breast cancer	0.000626	0.00105	CcSEcCtD
Methsuximide—Dermatitis—Thiotepa—breast cancer	0.000625	0.00105	CcSEcCtD
Methsuximide—Headache—Thiotepa—breast cancer	0.000622	0.00104	CcSEcCtD
Methsuximide—Somnolence—Paclitaxel—breast cancer	0.000621	0.00104	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000621	0.00104	CcSEcCtD
Methsuximide—Pancytopenia—Doxorubicin—breast cancer	0.000617	0.00103	CcSEcCtD
Methsuximide—Nausea—Vinorelbine—breast cancer	0.000617	0.00103	CcSEcCtD
Methsuximide—Decreased appetite—Paclitaxel—breast cancer	0.000608	0.00102	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000603	0.00101	CcSEcCtD
Methsuximide—Constipation—Paclitaxel—breast cancer	0.000598	0.001	CcSEcCtD
Methsuximide—Haematuria—Epirubicin—breast cancer	0.000597	0.001	CcSEcCtD
Methsuximide—Confusional state—Docetaxel—breast cancer	0.000597	0.001	CcSEcCtD
Methsuximide—Nausea—Thiotepa—breast cancer	0.000589	0.000986	CcSEcCtD
Methsuximide—Weight decreased—Doxorubicin—breast cancer	0.000588	0.000984	CcSEcCtD
Methsuximide—Diarrhoea—Irinotecan—breast cancer	0.000586	0.000981	CcSEcCtD
Methsuximide—Diarrhoea—Mitoxantrone—breast cancer	0.000586	0.000981	CcSEcCtD
Methsuximide—Drowsiness—Doxorubicin—breast cancer	0.00058	0.00097	CcSEcCtD
Methsuximide—Confusional state—Capecitabine—breast cancer	0.000578	0.000968	CcSEcCtD
Methsuximide—Feeling abnormal—Paclitaxel—breast cancer	0.000576	0.000964	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000575	0.000962	CcSEcCtD
Methsuximide—Gastrointestinal pain—Paclitaxel—breast cancer	0.000571	0.000956	CcSEcCtD
Methsuximide—Diarrhoea—Gemcitabine—breast cancer	0.000571	0.000956	CcSEcCtD
Methsuximide—Erythema multiforme—Methotrexate—breast cancer	0.000568	0.000951	CcSEcCtD
Methsuximide—Dizziness—Irinotecan—breast cancer	0.000567	0.000948	CcSEcCtD
Methsuximide—Anorexia—Docetaxel—breast cancer	0.000565	0.000945	CcSEcCtD
Methsuximide—Diarrhoea—Fluorouracil—breast cancer	0.000562	0.00094	CcSEcCtD
Methsuximide—Urticaria—Paclitaxel—breast cancer	0.000555	0.000929	CcSEcCtD
Methsuximide—Haematuria—Doxorubicin—breast cancer	0.000553	0.000925	CcSEcCtD
Methsuximide—Abdominal pain—Paclitaxel—breast cancer	0.000552	0.000925	CcSEcCtD
Methsuximide—Anorexia—Capecitabine—breast cancer	0.000547	0.000915	CcSEcCtD
Methsuximide—Vomiting—Irinotecan—breast cancer	0.000545	0.000912	CcSEcCtD
Methsuximide—Vomiting—Mitoxantrone—breast cancer	0.000545	0.000912	CcSEcCtD
Methsuximide—Dizziness—Fluorouracil—breast cancer	0.000543	0.000908	CcSEcCtD
Methsuximide—Rash—Irinotecan—breast cancer	0.00054	0.000904	CcSEcCtD
Methsuximide—Rash—Mitoxantrone—breast cancer	0.00054	0.000904	CcSEcCtD
Methsuximide—Dermatitis—Mitoxantrone—breast cancer	0.00054	0.000903	CcSEcCtD
Methsuximide—Dermatitis—Irinotecan—breast cancer	0.00054	0.000903	CcSEcCtD
Methsuximide—Headache—Irinotecan—breast cancer	0.000537	0.000898	CcSEcCtD
Methsuximide—Headache—Mitoxantrone—breast cancer	0.000537	0.000898	CcSEcCtD
Methsuximide—Insomnia—Docetaxel—breast cancer	0.000536	0.000897	CcSEcCtD
Methsuximide—Erythema multiforme—Epirubicin—breast cancer	0.000532	0.00089	CcSEcCtD
Methsuximide—Vomiting—Gemcitabine—breast cancer	0.000531	0.000888	CcSEcCtD
Methsuximide—Somnolence—Docetaxel—breast cancer	0.000527	0.000881	CcSEcCtD
Methsuximide—Rash—Gemcitabine—breast cancer	0.000526	0.000881	CcSEcCtD
Methsuximide—Dermatitis—Gemcitabine—breast cancer	0.000526	0.00088	CcSEcCtD
Methsuximide—Pethidine—CYP2D6—breast cancer	0.000524	0.0253	CrCbGaD
Methsuximide—Headache—Gemcitabine—breast cancer	0.000523	0.000875	CcSEcCtD
Methsuximide—Vomiting—Fluorouracil—breast cancer	0.000522	0.000873	CcSEcCtD
Methsuximide—Insomnia—Capecitabine—breast cancer	0.000519	0.000868	CcSEcCtD
Methsuximide—Rash—Fluorouracil—breast cancer	0.000517	0.000866	CcSEcCtD
Methsuximide—Dermatitis—Fluorouracil—breast cancer	0.000517	0.000865	CcSEcCtD
Methsuximide—Decreased appetite—Docetaxel—breast cancer	0.000515	0.000862	CcSEcCtD
Methsuximide—Headache—Fluorouracil—breast cancer	0.000514	0.000861	CcSEcCtD
Methsuximide—Ketazolam—CYP3A4—breast cancer	0.000514	0.0248	CrCbGaD
Methsuximide—Gastrointestinal disorder—Docetaxel—breast cancer	0.000511	0.000856	CcSEcCtD
Methsuximide—Nausea—Mitoxantrone—breast cancer	0.000509	0.000852	CcSEcCtD
Methsuximide—Nausea—Irinotecan—breast cancer	0.000509	0.000852	CcSEcCtD
Methsuximide—Constipation—Docetaxel—breast cancer	0.000507	0.000848	CcSEcCtD
Methsuximide—Primidone—CYP3A4—breast cancer	0.000503	0.0243	CrCbGaD
Methsuximide—Decreased appetite—Capecitabine—breast cancer	0.000499	0.000834	CcSEcCtD
Methsuximide—Phenobarbital—CYP1A1—breast cancer	0.000497	0.024	CrCbGaD
Methsuximide—Nausea—Gemcitabine—breast cancer	0.000496	0.00083	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Capecitabine—breast cancer	0.000495	0.000829	CcSEcCtD
Methsuximide—Vision blurred—Methotrexate—breast cancer	0.000493	0.000825	CcSEcCtD
Methsuximide—Erythema multiforme—Doxorubicin—breast cancer	0.000492	0.000823	CcSEcCtD
Methsuximide—Constipation—Capecitabine—breast cancer	0.00049	0.000821	CcSEcCtD
Methsuximide—Feeling abnormal—Docetaxel—breast cancer	0.000488	0.000817	CcSEcCtD
Methsuximide—Nausea—Fluorouracil—breast cancer	0.000487	0.000816	CcSEcCtD
Methsuximide—Gastrointestinal pain—Docetaxel—breast cancer	0.000484	0.000811	CcSEcCtD
Methsuximide—Tension—Epirubicin—breast cancer	0.00048	0.000804	CcSEcCtD
Methsuximide—Diarrhoea—Paclitaxel—breast cancer	0.000478	0.0008	CcSEcCtD
Methsuximide—Nervousness—Epirubicin—breast cancer	0.000475	0.000796	CcSEcCtD
Methsuximide—Feeling abnormal—Capecitabine—breast cancer	0.000473	0.000791	CcSEcCtD
Methsuximide—Gastrointestinal pain—Capecitabine—breast cancer	0.000469	0.000785	CcSEcCtD
Methsuximide—Abdominal pain—Docetaxel—breast cancer	0.000468	0.000784	CcSEcCtD
Methsuximide—Leukopenia—Methotrexate—breast cancer	0.000468	0.000784	CcSEcCtD
Methsuximide—Dizziness—Paclitaxel—breast cancer	0.000462	0.000773	CcSEcCtD
Methsuximide—Vision blurred—Epirubicin—breast cancer	0.000461	0.000772	CcSEcCtD
Methsuximide—Urticaria—Capecitabine—breast cancer	0.000456	0.000763	CcSEcCtD
Methsuximide—Abdominal pain—Capecitabine—breast cancer	0.000453	0.000759	CcSEcCtD
Methsuximide—Pethidine—CYP3A4—breast cancer	0.000449	0.0217	CrCbGaD
Methsuximide—Ketazolam—ALB—breast cancer	0.000448	0.0216	CrCbGaD
Methsuximide—Tension—Doxorubicin—breast cancer	0.000445	0.000744	CcSEcCtD
Methsuximide—Vomiting—Paclitaxel—breast cancer	0.000444	0.000744	CcSEcCtD
Methsuximide—Rash—Paclitaxel—breast cancer	0.000441	0.000737	CcSEcCtD
Methsuximide—Dermatitis—Paclitaxel—breast cancer	0.00044	0.000737	CcSEcCtD
Methsuximide—Nervousness—Doxorubicin—breast cancer	0.00044	0.000736	CcSEcCtD
Methsuximide—Leukopenia—Epirubicin—breast cancer	0.000438	0.000733	CcSEcCtD
Methsuximide—Headache—Paclitaxel—breast cancer	0.000438	0.000733	CcSEcCtD
Methsuximide—Confusional state—Methotrexate—breast cancer	0.00043	0.00072	CcSEcCtD
Methsuximide—Ketazolam—ABCB1—breast cancer	0.000428	0.0207	CrCbGaD
Methsuximide—Vision blurred—Doxorubicin—breast cancer	0.000427	0.000714	CcSEcCtD
Methsuximide—Nausea—Paclitaxel—breast cancer	0.000415	0.000695	CcSEcCtD
Methsuximide—Anorexia—Methotrexate—breast cancer	0.000407	0.000681	CcSEcCtD
Methsuximide—Leukopenia—Doxorubicin—breast cancer	0.000405	0.000679	CcSEcCtD
Methsuximide—Diarrhoea—Docetaxel—breast cancer	0.000405	0.000678	CcSEcCtD
Methsuximide—Confusional state—Epirubicin—breast cancer	0.000403	0.000674	CcSEcCtD
Methsuximide—Diarrhoea—Capecitabine—breast cancer	0.000392	0.000657	CcSEcCtD
Methsuximide—Pethidine—ALB—breast cancer	0.000392	0.0189	CrCbGaD
Methsuximide—Dizziness—Docetaxel—breast cancer	0.000392	0.000656	CcSEcCtD
Methsuximide—Insomnia—Methotrexate—breast cancer	0.000386	0.000646	CcSEcCtD
Methsuximide—Anorexia—Epirubicin—breast cancer	0.000381	0.000637	CcSEcCtD
Methsuximide—Somnolence—Methotrexate—breast cancer	0.00038	0.000635	CcSEcCtD
Methsuximide—Dizziness—Capecitabine—breast cancer	0.000379	0.000635	CcSEcCtD
Methsuximide—Vomiting—Docetaxel—breast cancer	0.000377	0.00063	CcSEcCtD
Methsuximide—Rash—Docetaxel—breast cancer	0.000373	0.000625	CcSEcCtD
Methsuximide—Dermatitis—Docetaxel—breast cancer	0.000373	0.000625	CcSEcCtD
Methsuximide—Confusional state—Doxorubicin—breast cancer	0.000373	0.000624	CcSEcCtD
Methsuximide—Decreased appetite—Methotrexate—breast cancer	0.000371	0.000621	CcSEcCtD
Methsuximide—Headache—Docetaxel—breast cancer	0.000371	0.000621	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Methotrexate—breast cancer	0.000369	0.000617	CcSEcCtD
Methsuximide—Vomiting—Capecitabine—breast cancer	0.000365	0.00061	CcSEcCtD
Methsuximide—Clobazam—CYP3A4—breast cancer	0.000363	0.0175	CrCbGaD
Methsuximide—Rash—Capecitabine—breast cancer	0.000362	0.000605	CcSEcCtD
Methsuximide—Insomnia—Epirubicin—breast cancer	0.000361	0.000605	CcSEcCtD
Methsuximide—Dermatitis—Capecitabine—breast cancer	0.000361	0.000605	CcSEcCtD
Methsuximide—Headache—Capecitabine—breast cancer	0.000359	0.000601	CcSEcCtD
Methsuximide—Somnolence—Epirubicin—breast cancer	0.000355	0.000594	CcSEcCtD
Methsuximide—Anorexia—Doxorubicin—breast cancer	0.000352	0.00059	CcSEcCtD
Methsuximide—Nausea—Docetaxel—breast cancer	0.000352	0.000589	CcSEcCtD
Methsuximide—Feeling abnormal—Methotrexate—breast cancer	0.000352	0.000589	CcSEcCtD
Methsuximide—Gastrointestinal pain—Methotrexate—breast cancer	0.000349	0.000584	CcSEcCtD
Methsuximide—Decreased appetite—Epirubicin—breast cancer	0.000347	0.000581	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Epirubicin—breast cancer	0.000345	0.000577	CcSEcCtD
Methsuximide—Constipation—Epirubicin—breast cancer	0.000342	0.000572	CcSEcCtD
Methsuximide—Nausea—Capecitabine—breast cancer	0.000341	0.00057	CcSEcCtD
Methsuximide—Urticaria—Methotrexate—breast cancer	0.000339	0.000568	CcSEcCtD
Methsuximide—Abdominal pain—Methotrexate—breast cancer	0.000338	0.000565	CcSEcCtD
Methsuximide—Insomnia—Doxorubicin—breast cancer	0.000334	0.00056	CcSEcCtD
Methsuximide—Phenytoin—CYP3A4—breast cancer	0.000331	0.016	CrCbGaD
Methsuximide—Feeling abnormal—Epirubicin—breast cancer	0.000329	0.000551	CcSEcCtD
Methsuximide—Somnolence—Doxorubicin—breast cancer	0.000329	0.00055	CcSEcCtD
Methsuximide—Gastrointestinal pain—Epirubicin—breast cancer	0.000327	0.000547	CcSEcCtD
Methsuximide—Decreased appetite—Doxorubicin—breast cancer	0.000321	0.000538	CcSEcCtD
Methsuximide—CYP2C19—Metapathway biotransformation—SULT1A1—breast cancer	0.00032	0.000896	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GPX4—breast cancer	0.00032	0.000896	CbGpPWpGaD
Methsuximide—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000319	0.000534	CcSEcCtD
Methsuximide—Urticaria—Epirubicin—breast cancer	0.000317	0.000531	CcSEcCtD
Methsuximide—Phenobarbital—CYP3A4—breast cancer	0.000317	0.0153	CrCbGaD
Methsuximide—CYP2C19—Biological oxidations—GSTA1—breast cancer	0.000317	0.000887	CbGpPWpGaD
Methsuximide—Constipation—Doxorubicin—breast cancer	0.000316	0.000529	CcSEcCtD
Methsuximide—Abdominal pain—Epirubicin—breast cancer	0.000316	0.000529	CcSEcCtD
Methsuximide—CYP2C19—Biological oxidations—NAT2—breast cancer	0.000313	0.000877	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MMP9—breast cancer	0.000312	0.000873	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—NAT2—breast cancer	0.000309	0.000865	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP2—breast cancer	0.000306	0.000856	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—AKT2—breast cancer	0.000306	0.000855	CbGpPWpGaD
Methsuximide—Feeling abnormal—Doxorubicin—breast cancer	0.000305	0.00051	CcSEcCtD
Methsuximide—Gastrointestinal pain—Doxorubicin—breast cancer	0.000302	0.000506	CcSEcCtD
Methsuximide—Clobazam—ABCB1—breast cancer	0.000302	0.0146	CrCbGaD
Methsuximide—CACNA1H—Axon guidance—MMP2—breast cancer	0.000296	0.000829	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP2—breast cancer	0.000296	0.000828	CbGpPWpGaD
Methsuximide—Urticaria—Doxorubicin—breast cancer	0.000294	0.000492	CcSEcCtD
Methsuximide—Abdominal pain—Doxorubicin—breast cancer	0.000292	0.000489	CcSEcCtD
Methsuximide—Diarrhoea—Methotrexate—breast cancer	0.000292	0.000489	CcSEcCtD
Methsuximide—Phenytoin—ALB—breast cancer	0.000289	0.014	CrCbGaD
Methsuximide—CACNA1I—Axon guidance—SRC—breast cancer	0.000288	0.000805	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—FGFR1—breast cancer	0.000284	0.000794	CbGpPWpGaD
Methsuximide—Dizziness—Methotrexate—breast cancer	0.000282	0.000473	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—VEGFA—breast cancer	0.00028	0.000784	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	0.000276	0.000773	CbGpPWpGaD
Methsuximide—Phenytoin—ABCB1—breast cancer	0.000276	0.0133	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—FGFR1—breast cancer	0.000275	0.000769	CbGpPWpGaD
Methsuximide—Diarrhoea—Epirubicin—breast cancer	0.000273	0.000458	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—LEP—breast cancer	0.000273	0.000764	CbGpPWpGaD
Methsuximide—Vomiting—Methotrexate—breast cancer	0.000271	0.000454	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—RAF1—breast cancer	0.000271	0.000758	CbGpPWpGaD
Methsuximide—Rash—Methotrexate—breast cancer	0.000269	0.000451	CcSEcCtD
Methsuximide—Dermatitis—Methotrexate—breast cancer	0.000269	0.00045	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—ERBB2—breast cancer	0.000268	0.00075	CbGpPWpGaD
Methsuximide—Headache—Methotrexate—breast cancer	0.000267	0.000448	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—KDR—breast cancer	0.000267	0.000748	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	0.000265	0.000742	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MAPK3—breast cancer	0.000265	0.000741	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—LEP—breast cancer	0.000264	0.00074	CbGpPWpGaD
Methsuximide—Dizziness—Epirubicin—breast cancer	0.000264	0.000442	CcSEcCtD
Methsuximide—Phenobarbital—ABCB1—breast cancer	0.000264	0.0128	CrCbGaD
Methsuximide—CACNA1H—Axon guidance—RAF1—breast cancer	0.000262	0.000734	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—RAF1—breast cancer	0.000262	0.000734	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MET—breast cancer	0.000262	0.000732	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CDK4—breast cancer	0.000262	0.000732	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—RELA—breast cancer	0.000261	0.000731	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ERBB2—breast cancer	0.00026	0.000726	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ERBB2—breast cancer	0.000259	0.000726	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—KDR—breast cancer	0.000259	0.000725	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—MTR—breast cancer	0.000256	0.000715	CbGpPWpGaD
Methsuximide—Vomiting—Epirubicin—breast cancer	0.000254	0.000425	CcSEcCtD
Methsuximide—Nausea—Methotrexate—breast cancer	0.000254	0.000424	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—CDK4—breast cancer	0.000253	0.000709	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MET—breast cancer	0.000253	0.000709	CbGpPWpGaD
Methsuximide—Diarrhoea—Doxorubicin—breast cancer	0.000253	0.000423	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—EGFR—breast cancer	0.000252	0.000705	CbGpPWpGaD
Methsuximide—Rash—Epirubicin—breast cancer	0.000252	0.000422	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—NOTCH1—breast cancer	0.000252	0.000705	CbGpPWpGaD
Methsuximide—Dermatitis—Epirubicin—breast cancer	0.000252	0.000421	CcSEcCtD
Methsuximide—CYP2C19—Biological oxidations—HPGDS—breast cancer	0.000251	0.000701	CbGpPWpGaD
Methsuximide—Headache—Epirubicin—breast cancer	0.00025	0.000419	CcSEcCtD
Methsuximide—Dizziness—Doxorubicin—breast cancer	0.000244	0.000409	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—NOTCH1—breast cancer	0.000244	0.000683	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTT1—breast cancer	0.000243	0.00068	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—KRAS—breast cancer	0.000238	0.000666	CbGpPWpGaD
Methsuximide—Nausea—Epirubicin—breast cancer	0.000237	0.000397	CcSEcCtD
Methsuximide—Vomiting—Doxorubicin—breast cancer	0.000235	0.000393	CcSEcCtD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—breast cancer	0.000234	0.000656	CbGpPWpGaD
Methsuximide—Rash—Doxorubicin—breast cancer	0.000233	0.00039	CcSEcCtD
Methsuximide—Dermatitis—Doxorubicin—breast cancer	0.000233	0.00039	CcSEcCtD
Methsuximide—Headache—Doxorubicin—breast cancer	0.000232	0.000388	CcSEcCtD
Methsuximide—CYP2C19—Biological oxidations—CYP17A1—breast cancer	0.00023	0.000644	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP9—breast cancer	0.00023	0.000643	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—PTGS1—breast cancer	0.000228	0.000637	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CTNNB1—breast cancer	0.000227	0.000635	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP17A1—breast cancer	0.000227	0.000635	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—AKT2—breast cancer	0.000225	0.000631	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP2D6—breast cancer	0.000223	0.000625	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP9—breast cancer	0.000223	0.000623	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP9—breast cancer	0.000223	0.000623	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP2D6—breast cancer	0.00022	0.000616	CbGpPWpGaD
Methsuximide—Nausea—Doxorubicin—breast cancer	0.00022	0.000368	CcSEcCtD
Methsuximide—CYP2C19—Biological oxidations—NCOA2—breast cancer	0.000219	0.000613	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP2—breast cancer	0.000218	0.000611	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT2—breast cancer	0.000218	0.000611	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—SRC—breast cancer	0.000212	0.000593	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP2—breast cancer	0.000211	0.000592	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—VEGFA—breast cancer	0.000206	0.000578	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—SRC—breast cancer	0.000205	0.000574	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SRC—breast cancer	0.000205	0.000574	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—HRAS—breast cancer	0.000202	0.000566	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—VEGFA—breast cancer	0.0002	0.000559	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—VEGFA—breast cancer	0.0002	0.000559	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—STAT3—breast cancer	0.000198	0.000554	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP3A4—breast cancer	0.000197	0.000551	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MAPK3—breast cancer	0.000195	0.000546	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP3A4—breast cancer	0.000194	0.000544	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—IL6—breast cancer	0.000194	0.000542	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP1B1—breast cancer	0.000194	0.000542	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.000193	0.000541	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—RAF1—breast cancer	0.000193	0.000541	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—RELA—breast cancer	0.000192	0.000539	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ERBB2—breast cancer	0.000191	0.000535	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP1B1—breast cancer	0.000191	0.000534	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MAPK3—breast cancer	0.000189	0.000529	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MAPK3—breast cancer	0.000189	0.000529	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—RAF1—breast cancer	0.000187	0.000524	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—RELA—breast cancer	0.000186	0.000522	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—EGFR—breast cancer	0.000186	0.00052	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ERBB2—breast cancer	0.000185	0.000518	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—NCOA1—breast cancer	0.000185	0.000517	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TGFB1—breast cancer	0.000183	0.000513	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP19A1—breast cancer	0.000182	0.000509	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—EGFR—breast cancer	0.00018	0.000503	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—EGFR—breast cancer	0.00018	0.000503	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP19A1—breast cancer	0.00018	0.000502	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.000176	0.000491	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.000176	0.000491	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—KRAS—breast cancer	0.000176	0.000491	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TNF—breast cancer	0.000171	0.000479	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—KRAS—breast cancer	0.00017	0.000476	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—KRAS—breast cancer	0.00017	0.000475	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—COMT—breast cancer	0.000169	0.000474	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTP1—breast cancer	0.000168	0.000471	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CTNNB1—breast cancer	0.000167	0.000468	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—COMT—breast cancer	0.000167	0.000467	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.000166	0.000466	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTP1—breast cancer	0.000166	0.000465	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP9—breast cancer	0.000164	0.000459	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CTNNB1—breast cancer	0.000162	0.000453	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP9—breast cancer	0.000159	0.000445	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTM1—breast cancer	0.000155	0.000433	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTM1—breast cancer	0.000153	0.000427	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.000152	0.000426	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SRC—breast cancer	0.000151	0.000423	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—HRAS—breast cancer	0.000149	0.000417	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—VEGFA—breast cancer	0.000147	0.000412	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP1A1—breast cancer	0.000147	0.000411	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SRC—breast cancer	0.000147	0.00041	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—STAT3—breast cancer	0.000146	0.000408	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP1A1—breast cancer	0.000145	0.000405	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—HRAS—breast cancer	0.000144	0.000404	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—HRAS—breast cancer	0.000144	0.000404	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6—breast cancer	0.000143	0.0004	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—VEGFA—breast cancer	0.000143	0.000399	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.000142	0.000396	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—STAT3—breast cancer	0.000141	0.000395	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MAPK3—breast cancer	0.000139	0.00039	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6—breast cancer	0.000138	0.000387	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6—breast cancer	0.000138	0.000387	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.000137	0.000384	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TGFB1—breast cancer	0.000135	0.000378	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MAPK3—breast cancer	0.000135	0.000378	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—EGFR—breast cancer	0.000133	0.000371	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TGFB1—breast cancer	0.000131	0.000366	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—EGFR—breast cancer	0.000128	0.000359	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—AKT1—breast cancer	0.000128	0.000357	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TNF—breast cancer	0.000126	0.000353	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.000126	0.000353	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—KRAS—breast cancer	0.000125	0.00035	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.000125	0.000349	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TNF—breast cancer	0.000122	0.000342	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.000122	0.000341	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—KRAS—breast cancer	0.000121	0.000339	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SYNJ2—breast cancer	0.000118	0.00033	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NDUFS3—breast cancer	0.00011	0.000307	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—HRAS—breast cancer	0.000106	0.000298	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.000106	0.000295	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CHST9—breast cancer	0.000103	0.000289	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—HRAS—breast cancer	0.000103	0.000288	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6—breast cancer	0.000102	0.000285	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.000101	0.000282	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6—breast cancer	9.87e-05	0.000276	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	9.81e-05	0.000275	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—COX11—breast cancer	9.78e-05	0.000274	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	9.62e-05	0.000269	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—AKT1—breast cancer	9.4e-05	0.000263	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—breast cancer	9.33e-05	0.000261	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT1—breast cancer	9.1e-05	0.000255	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SHMT1—breast cancer	8.95e-05	0.00025	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CDA—breast cancer	8.95e-05	0.00025	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	8.83e-05	0.000247	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	8.75e-05	0.000245	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A5—breast cancer	8.61e-05	0.000241	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLCO1B1—breast cancer	8.61e-05	0.000241	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	8.42e-05	0.000236	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APRT—breast cancer	8.32e-05	0.000233	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	8.16e-05	0.000228	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	8.13e-05	0.000227	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ESRRA—breast cancer	7.82e-05	0.000219	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ANGPTL4—breast cancer	7.82e-05	0.000219	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	7.44e-05	0.000208	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HADHB—breast cancer	7.41e-05	0.000207	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPI—breast cancer	7.41e-05	0.000207	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	7.09e-05	0.000198	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH7A1—breast cancer	7.07e-05	0.000198	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH1A1—breast cancer	7.07e-05	0.000198	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	6.99e-05	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PHGDH—breast cancer	6.78e-05	0.00019	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADSL—breast cancer	6.78e-05	0.00019	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—UMPS—breast cancer	6.78e-05	0.00019	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NME1—breast cancer	6.78e-05	0.00019	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—FHL2—breast cancer	6.78e-05	0.00019	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HPSE—breast cancer	6.65e-05	0.000186	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—BRIP1—breast cancer	6.65e-05	0.000186	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LDHB—breast cancer	6.65e-05	0.000186	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTA3—breast cancer	6.3e-05	0.000176	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCC1—breast cancer	6.3e-05	0.000176	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMMR—breast cancer	6.3e-05	0.000176	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARGC1B—breast cancer	6.11e-05	0.000171	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	5.94e-05	0.000166	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	5.94e-05	0.000166	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA9—breast cancer	5.77e-05	0.000161	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTA4—breast cancer	5.77e-05	0.000161	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	5.69e-05	0.000159	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	5.64e-05	0.000158	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX2—breast cancer	5.62e-05	0.000157	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTA2—breast cancer	5.62e-05	0.000157	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SULT1A1—breast cancer	5.55e-05	0.000155	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX4—breast cancer	5.55e-05	0.000155	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—IDH1—breast cancer	5.42e-05	0.000152	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTA1—breast cancer	5.42e-05	0.000152	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NAT2—breast cancer	5.36e-05	0.00015	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.85e-05	0.000136	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—DPYD—breast cancer	4.7e-05	0.000132	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MED12—breast cancer	4.7e-05	0.000132	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDOA—breast cancer	4.63e-05	0.000129	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NCOA3—breast cancer	4.49e-05	0.000126	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A2—breast cancer	4.46e-05	0.000125	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.41e-05	0.000124	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CPT1A—breast cancer	4.37e-05	0.000122	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCG2—breast cancer	4.37e-05	0.000122	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MTR—breast cancer	4.37e-05	0.000122	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HPGDS—breast cancer	4.29e-05	0.00012	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HBA1—breast cancer	4.26e-05	0.000119	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTT1—breast cancer	4.16e-05	0.000116	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ACHE—breast cancer	4.16e-05	0.000116	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP17A1—breast cancer	3.93e-05	0.00011	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS1—breast cancer	3.89e-05	0.000109	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ENO1—breast cancer	3.89e-05	0.000109	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.88e-05	0.000109	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.83e-05	0.000107	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP2D6—breast cancer	3.82e-05	0.000107	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NCOA2—breast cancer	3.75e-05	0.000105	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—FASN—breast cancer	3.64e-05	0.000102	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—BCHE—breast cancer	3.62e-05	0.000101	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC5A5—breast cancer	3.58e-05	0.0001	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A1—breast cancer	3.45e-05	9.66e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NQO1—breast cancer	3.45e-05	9.66e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.38e-05	9.46e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP3A4—breast cancer	3.37e-05	9.42e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.35e-05	9.38e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP1B1—breast cancer	3.31e-05	9.27e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.25e-05	9.09e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NCOA1—breast cancer	3.16e-05	8.84e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP19A1—breast cancer	3.11e-05	8.71e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—STK11—breast cancer	3.11e-05	8.71e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.92e-05	8.18e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—COMT—breast cancer	2.89e-05	8.1e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTP1—breast cancer	2.88e-05	8.06e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMOX1—breast cancer	2.84e-05	7.95e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ITPR1—breast cancer	2.83e-05	7.93e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCB1—breast cancer	2.73e-05	7.63e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TYMS—breast cancer	2.68e-05	7.49e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.65e-05	7.41e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NCOR1—breast cancer	2.65e-05	7.41e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTM1—breast cancer	2.65e-05	7.41e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX1—breast cancer	2.54e-05	7.09e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP1A1—breast cancer	2.51e-05	7.02e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ERCC2—breast cancer	2.49e-05	6.96e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MTHFR—breast cancer	2.34e-05	6.55e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CAV1—breast cancer	2.16e-05	6.04e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.06e-05	5.77e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CG—breast cancer	1.97e-05	5.5e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CD—breast cancer	1.73e-05	4.84e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALB—breast cancer	1.71e-05	4.77e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NOS3—breast cancer	1.63e-05	4.57e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CB—breast cancer	1.51e-05	4.21e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS2—breast cancer	1.49e-05	4.18e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTEN—breast cancer	1.3e-05	3.64e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CA—breast cancer	9.18e-06	2.57e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AKT1—breast cancer	7.5e-06	2.1e-05	CbGpPWpGaD
